Some 10 million Americans over 50 have the weak and brittle bones from osteoporosis, according to the Bone Health & ...

Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a ...

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...

In the course of evaluating the optimal duration of bisphosphonate treatment the FDA found little benefit of treatment beyond 5 years. [1,2] Moreover, examination of studies where bisphosphonates ...

On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...

Treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy. These highlights do not include all the information needed to use XBRYK safely and effectively. See full prescribing ...

Fragility fractures are increasingly prevalent in the aging population due to factors like osteoporosis and diminished bone ...

Some of these men and women will be prescribed a bisphosphonate or another drug without hesitation if needed. However, some of these men and women were not given the chance to maintain their bone ...

The use of antiresorptive drugs for tumor-related disorders and oral, but not injectable, corticosteroids were associated with an increased risk for osteonecrosis of the jaw among patients with ...

After the removal of a wisdom tooth, a person may find it beneficial to eat soft foods because they do not require chewing. For example, this may include soup, smoothies, yogurt, or oatmeal ...